Llwytho...
Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy
Colorectal cancer is the third most frequent cancer worldwide. Overall survival rates have improved greatly over the last few years due, at least in part, to the addition of targeted therapies to standard of care chemotherapy. Angiogenesis plays an important role in colorectal cancer, and therapies...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Adv Med Oncol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872251/ https://ncbi.nlm.nih.gov/pubmed/27239240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834016635888 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|